Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Johnson

Showing results (231-240 of 244) with videos related to

Pageof 25
Sort By:
The New England Journal of Medicine|June 21, 2013
Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphomaMichael L Wang, Simon Rule, Peter Martin, et al.
Blood Advances|August 10, 2022
Longitudinal expression profiling identifies a poor risk subset of patients with ABC-type diffuse large B-cell lymphomaFindlay Bewicke-Copley, Koorosh Korfi, Shamzah Araf, et al.
The Lancet. Haematology|May 3, 2016
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trialAndrés J M Ferreri, Kate Cwynarski, Elisa Pulczynski, et al.
Nature Genetics|December 23, 2015
Recurrent mTORC1-activating RRAGC mutations in follicular lymphomaJessica Okosun, Rachel L Wolfson, Jun Wang, et al.
Blood|January 15, 2020
Molecular MRD status and outcome after transplantation in NPM1-mutated AMLRichard Dillon, Robert Hills, Sylvie Freeman, et al.
Nature Genetics|May 28, 2016
Corrigendum: Recurrent mTORC1-activating RRAGC mutations in follicular lymphomaJessica Okosun, Rachel L Wolfson, Jun Wang, et al.
Elife|July 4, 2018
Nanoscale dysregulation of collagen structure-function disrupts mechano-homeostasis and mediates pulmonary fibrosisMark G Jones, Orestis G Andriotis, James Jw Roberts, et al.
The Lancet. Haematology|October 22, 2017
Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trialAndrés J M Ferreri, Kate Cwynarski, Elisa Pulczynski, et al.
The Lancet. Oncology|May 26, 2022
Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population-based test-negative case-control studyLennard Y W Lee, Thomas Starkey, Maria C Ionescu, et al.
Ecancermedicalscience|February 26, 2016
An Association of Cancer Physicians' strategy for improving services and outcomes for cancer patientsRichard Baird, Ian Banks, David Cameron, et al.
Pageof 25

Showing results (231-240 of 244) with videos related to

Sort By:
Pageof 25
The New England Journal of Medicine|June 21, 2013
Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphomaMichael L Wang, Simon Rule, Peter Martin, et al.
Blood Advances|August 10, 2022
Longitudinal expression profiling identifies a poor risk subset of patients with ABC-type diffuse large B-cell lymphomaFindlay Bewicke-Copley, Koorosh Korfi, Shamzah Araf, et al.
The Lancet. Haematology|May 3, 2016
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trialAndrés J M Ferreri, Kate Cwynarski, Elisa Pulczynski, et al.
Nature Genetics|December 23, 2015
Recurrent mTORC1-activating RRAGC mutations in follicular lymphomaJessica Okosun, Rachel L Wolfson, Jun Wang, et al.
Blood|January 15, 2020
Molecular MRD status and outcome after transplantation in NPM1-mutated AMLRichard Dillon, Robert Hills, Sylvie Freeman, et al.
Nature Genetics|May 28, 2016
Corrigendum: Recurrent mTORC1-activating RRAGC mutations in follicular lymphomaJessica Okosun, Rachel L Wolfson, Jun Wang, et al.
Elife|July 4, 2018
Nanoscale dysregulation of collagen structure-function disrupts mechano-homeostasis and mediates pulmonary fibrosisMark G Jones, Orestis G Andriotis, James Jw Roberts, et al.
The Lancet. Haematology|October 22, 2017
Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trialAndrés J M Ferreri, Kate Cwynarski, Elisa Pulczynski, et al.
The Lancet. Oncology|May 26, 2022
Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population-based test-negative case-control studyLennard Y W Lee, Thomas Starkey, Maria C Ionescu, et al.
Ecancermedicalscience|February 26, 2016
An Association of Cancer Physicians' strategy for improving services and outcomes for cancer patientsRichard Baird, Ian Banks, David Cameron, et al.
Pageof 25